[go: up one dir, main page]

IT1309584B1 - Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso. - Google Patents

Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.

Info

Publication number
IT1309584B1
IT1309584B1 IT1999MI000396A ITMI990396A IT1309584B1 IT 1309584 B1 IT1309584 B1 IT 1309584B1 IT 1999MI000396 A IT1999MI000396 A IT 1999MI000396A IT MI990396 A ITMI990396 A IT MI990396A IT 1309584 B1 IT1309584 B1 IT 1309584B1
Authority
IT
Italy
Prior art keywords
mage
mhc
class
presented
peptides derived
Prior art date
Application number
IT1999MI000396A
Other languages
English (en)
Inventor
Maria Pia Protti
Paolo Dellabona
Original Assignee
San Raffaele Centro Fond
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Raffaele Centro Fond filed Critical San Raffaele Centro Fond
Priority to IT1999MI000396A priority Critical patent/IT1309584B1/it
Priority to CA002364002A priority patent/CA2364002A1/en
Priority to JP2000602269A priority patent/JP2002538166A/ja
Priority to PCT/EP2000/001458 priority patent/WO2000052045A2/en
Priority to EP00907601A priority patent/EP1161443A2/en
Priority to AU29134/00A priority patent/AU2913400A/en
Publication of ITMI990396A1 publication Critical patent/ITMI990396A1/it
Application granted granted Critical
Publication of IT1309584B1 publication Critical patent/IT1309584B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT1999MI000396A 1999-02-26 1999-02-26 Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso. IT1309584B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT1999MI000396A IT1309584B1 (it) 1999-02-26 1999-02-26 Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.
CA002364002A CA2364002A1 (en) 1999-02-26 2000-02-23 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof
JP2000602269A JP2002538166A (ja) 1999-02-26 2000-02-23 Ｍｈｃクラスｉｉによって提示されるｍａｇｅ−３由来免疫原性ペプチドおよびその使用
PCT/EP2000/001458 WO2000052045A2 (en) 1999-02-26 2000-02-23 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof
EP00907601A EP1161443A2 (en) 1999-02-26 2000-02-23 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof
AU29134/00A AU2913400A (en) 1999-02-26 2000-02-23 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000396A IT1309584B1 (it) 1999-02-26 1999-02-26 Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.

Publications (2)

Publication Number Publication Date
ITMI990396A1 ITMI990396A1 (it) 2000-08-26
IT1309584B1 true IT1309584B1 (it) 2002-01-24

Family

ID=11382063

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI000396A IT1309584B1 (it) 1999-02-26 1999-02-26 Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.

Country Status (6)

Country Link
EP (1) EP1161443A2 (it)
JP (1) JP2002538166A (it)
AU (1) AU2913400A (it)
CA (1) CA2364002A1 (it)
IT (1) IT1309584B1 (it)
WO (1) WO2000052045A2 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074847A2 (en) * 2000-03-30 2001-10-11 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
US7049413B2 (en) 2001-05-18 2006-05-23 Ludwig Institute For Cancer Research MAGE-A3 peptides presented by HLA class II molecules
AU2002322009A1 (en) 2001-05-18 2002-12-03 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
FR2837837B1 (fr) * 2002-03-28 2006-09-29 Roussy Inst Gustave Epitopes peptidiques communs a des antigenes d'une meme famille multigenique
EP1715343B1 (en) * 2005-04-20 2009-12-09 F. Hoffmann-La Roche Ag Method for the identification of epitopes related to immunogenicity in biopharmaceuticals
WO2008053573A1 (en) * 2006-10-30 2008-05-08 National University Corporation Hokkaido University Remedy for malignant neoplasm
TWI546381B (zh) * 2014-05-30 2016-08-21 中央研究院 用以標的黑色素瘤相關抗原a3胜肽之寡核苷酸適體及其用途
GB201804468D0 (en) * 2018-03-21 2018-05-02 Valo Therapeutics Oy PeptiCRAd Cancer Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
BR9406652A (pt) * 1993-03-05 1996-09-10 Cytel Corp Composição
CA2278189A1 (en) * 1997-01-31 1998-08-06 Epimmune, Inc. Peptides and peptide-loaded antigen presenting cells for the activation of ctl
KR100480546B1 (ko) * 1997-07-15 2005-04-06 다카라 바이오 가부시키가이샤 세포독성 티 림프구
US5965535A (en) * 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
EP1064022A4 (en) * 1998-03-13 2004-09-29 Epimmune Inc HLA BINDING PEPTIDES AND THEIR APPLICATIONS

Also Published As

Publication number Publication date
AU2913400A (en) 2000-09-21
CA2364002A1 (en) 2000-09-08
EP1161443A2 (en) 2001-12-12
WO2000052045A2 (en) 2000-09-08
WO2000052045A3 (en) 2001-01-04
ITMI990396A1 (it) 2000-08-26
JP2002538166A (ja) 2002-11-12

Similar Documents

Publication Publication Date Title
ATE321569T1 (de) Kombinierte impfstoffzusammensetzungen
ATE490327T1 (de) Impfstoffzusammensetzung
ATE413188T1 (de) Menschliche papillomavirus impfstoff- formulierungen
NO20014322D0 (no) Vaksine
CY1111413T1 (el) Ελευθερα απο ψευδαργυρο και φτωχα σε ψευδαργυρο σκευασματα ινσουλινης με βελτιωμενη σταθεροτητα
ATE339223T1 (de) Kombinierte impfstoffzusammensetzungen
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
DZ3219A1 (fr) Vaccin
DE60002650D1 (de) Öladjuvierter Impfstoff
BR0010418B1 (pt) microorganismo de salmonella, composiÇço de vacina e uso do referido microorganismo.
AU2273701A (en) Hla class i a2 tumor associated antigen peptides and vaccine compositions
IT1318319B1 (it) Composizione di gomma, procedimento per produrre la stessa e manicottoutilizzante la composizione di gomma.
NO20015670L (no) Forbedrede farmasöytiske formuleringer
IT1314191B1 (it) Derivati isossazolcarbossamidici
DK1356822T3 (da) Farmaceutiske sammensætninger, der forøger immunogeniteten af svagt immunogene antigener
IT1309584B1 (it) Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.
FR2798291B1 (fr) Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
DK1331935T3 (da) Derivater af tryptamin og analoge forbindelser samt farmaceutiske formuleringer deraf
ITBZ20010003U1 (it) Dispositivo per la protezione di edifici da piene.
IT1313592B1 (it) Derivati di 1h-pirido 3,4-b indol-1-one.
IT1313660B1 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani.
IT1314259B1 (it) Procedimento per la preparazione di eteri derivati da acidiidrossibenzoici.
DK1180041T3 (da) Vaccine med ISA-virus
IT1312568B1 (it) Peptidi immunogenici e loro uso.